Clinical study for Plasma Wire System (FIM-2)
Not Applicable
Recruiting
- Conditions
- Chronic total occlusion
- Registration Number
- JPRN-UMIN000027897
- Lead Sponsor
- Toyohashi Heart Center Cardiovascular Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the Plasma Wire System's efficacy in chronic total occlusion revascularization?
How does the Plasma Wire System compare to standard-of-care treatments for CTO in terms of procedural success and complications?
Are there specific biomarkers that can predict patient response to the Plasma Wire System in CTO interventions?
What are the potential adverse events associated with the Plasma Wire System and how are they managed in clinical practice?
What combination therapies or alternative devices are being explored alongside the Plasma Wire System for chronic total occlusion treatment?